Comments on: Monday Deal Review: August 3, 2009 http://crossborderbiotech.ca/2009/08/03/monday-deal-review-august-3-2009/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: November 23, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/08/03/monday-deal-review-august-3-2009/comment-page-1/#comment-1106 Tue, 24 Nov 2009 11:58:21 +0000 http://crossborderbiotech.ca/?p=2792#comment-1106 [...] November 16, 2009 is the record date, and the meeting will be held December 18, 2009.  Meanwhile, Advitech’s acquisition of ex-SemBioSys subsidiary Botaneco closed into [...]

]]> By: Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/08/03/monday-deal-review-august-3-2009/comment-page-1/#comment-1052 Mon, 26 Oct 2009 13:51:32 +0000 http://crossborderbiotech.ca/?p=2792#comment-1052 [...] shares of Botaneco Specialty Ingredients Inc., held by Avrio Ventures Limited Partnership and (a little, still by) SemBioSys Genetics Inc. (TSX: SBS) (SemBioSys’ release here).  Under the terms of the deal, [...]

]]> By: Monday Deal Review: August 28, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/08/03/monday-deal-review-august-3-2009/comment-page-1/#comment-886 Mon, 31 Aug 2009 11:08:12 +0000 http://crossborderbiotech.ca/?p=2792#comment-886 [...] Prism Medical Ltd. (TSX-V: PM) closed the private placement it launched a few weeks ago, issuing 350,118 common shares at $6.00 per share for gross proceeds of $2,100,708, shy of the announced $3 million target. [...]

]]>